Related Experiment Video
Updated: Feb 27, 2026

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
Cor Triatriatum Dexter: The Largest Comprehensive Review in the Field on 124 Worldwide Cases (1968-Now)
Pier Paolo Bassareo1,2,3, Erica Franco4, Sophie Duignan3
1School of Medicine, University College of Dublin, D04 V1W8 Dublin, Ireland.
Insights
Cor triatriatum dexter (CTD), a rare congenital heart defect, often presents with dyspnea and cyanosis. This comprehensive review highlights diagnostic methods, associated anomalies, and outcomes, with surgery being the preferred treatment.
Area of Science:
- Cardiology
- Congenital Heart Defects
- Medical Imaging
Background:
- Cor triatriatum dexter (CTD) is a rare congenital heart defect characterized by a dividing membrane in the right atrium.
- It arises from incomplete regression of the right valve of the sinus venosus.
- This review represents the most extensive analysis of CTD to date, synthesizing findings from case reports and series.
Purpose of the Study:
- To conduct a comprehensive review of Cor triatriatum dexter (CTD).
- To evaluate key factors including age at diagnosis, clinical presentation, diagnostic imaging, associated cardiac anomalies, and patient outcomes.
Main Methods:
- Systematic literature search of PubMed and Scopus databases.
- Inclusion of case reports and case series; exclusion of fetal, autopsy, and animal studies.
- Data primarily presented as percentages to summarize findings across 114 studies and 124 patients.
Main Results:
- The mean age at diagnosis was 33.3 years; common symptoms included dyspnea (44.3%) and cyanosis (29.5%).
- Echocardiography diagnosed CTD in 95.2% of cases; 67.7% had associated congenital heart defects, particularly atrial septal defects.
- Surgical correction was the primary treatment (51.6%), with a mortality rate of 8.2%.
Conclusions:
- This systematic review, while limited by its reliance on case reports, provides the most comprehensive analysis of Cor triatriatum dexter available.
- Findings underscore the importance of echocardiography in diagnosis and highlight the prevalence of associated cardiac anomalies.
- The study details current treatment strategies and outcomes for this rare condition.
Background:
Cor triatriatum dexter (CTD) is a rare congenital heart defect where a membrane divides the right atrium into two chambers, resulting from the incomplete regression of the right valve of the sinus venosus. Due to its rarity, only individual case reports and a limited number of case series have been published to date. This study constitutes the most extensive comprehensive review conducted in this area. Eight factors were evaluated: age at diagnosis, sex, clinical presentation, electrocardiographic findings, imaging (ultrasound, CT, or MRI), associated cardiac anomalies, and patient outcomes.
Methods:
The electronic databases PubMed and Scopus were searched from their inception until 30 October 2025. Only case reports and case series were considered for inclusion. Studies involving foetuses, autopsies, and animals were excluded. The collected data were primarily presented as percentages.
Results:
One hundred fourteen studies were found encompassing 124 patients. The mean age at diagnosis was 33.3 ± 9.4 years The most common clinical presentations were dyspnoea (44.3%) and cyanosis (29.5%). The most commonly encountered ECG changes were supraventricular tachycardia/atrial flutter/atrial fibrillation (33.3%) and right bundle branch block (22.6%). On chest X-ray, cardiomegaly was noted in 46.5%. CTD was suspected or diagnosed by echocardiography in 95.2% of cases. The diagnosis was confirmed by CT and/or MRI in 34.1% of cases. A concomitant congenital heart defect was found in 67.7%, especially in the form of all kinds of atrial septal defect (38.1%) and of right valvular and right ventricular involvement (20.1%). An outcome was reported in 97/124. Surgical correction was the treatment of choice in 51.6%. Since 1991, a percutaneous approach has been employed in selected cases (5.1%). Conservative management was the treatment of choice in 43.3%. The mortality rate was 8.2%.
Discussion:
The principal limitation of this systematic review lies in its reliance solely on case reports and small case series, reflecting the absence of large-scale studies on CTD. Nonetheless, it constitutes the most comprehensive analysis available to date.
More Related Videos
07:41Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
Published on: February 8, 2022
13:10Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA
Published on: April 24, 2017
Related Concept Videos
Mitral Stenosis II: Clinical features and Diagnostic Tests
Acute Coronary Syndrome III: Diagnostic Studies
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Mitral Stenosis I: Introduction